The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...

The University of Texas MD Anderson Cancer Center in Houston is partnering with SOPHiA GENETICS to advance the use of artificial intelligence in cancer diagnostics and research. Through the ...

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As compared with fulvestrant alone, the combination more than doubled the median ...

Researchers at the Keck School of Medicine of University of Southern California (USC) have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...

MEDITECH customer Fraser Health (Surrey, B.C.) ? the largest regional health authority in British Columbia ? has experienced significant improvements in patient discharge efficiency after implementing ...

India's hospital chains, diagnostics networks, and global investors have poured millions of dollars into gene sequencing, ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced strategic investments from new and existing investors to accelerate IMVARIA's growth and fuel ...

Data highlights the ability of Akari’s Trop2 ADC, AKTX-101, to kill K-Ras G12V mutated cancer cell lines in preclinical models, potentially addressing one of the most lethal cancers with the lowest ...

Researchers have developed a TRBC2-targeted antibody-drug conjugate for T-cell lymphomas and leukemias, addressing half of ...